黄芪、当归煎服治疗肾病综合征疗效观察  

The cure rate analysis of astragalus and angelica in the treatment of patients with nephrotin syndrome

作　　者：刘智[1] 齐晓玲[1] 袁玲[1] 

机构地区：[1]安徽淮南市第一人民医院肾内科,232007

出　　处：《中国基层医药》2001年第5期397-398,共2页Chinese Journal of Primary Medicine and Pharmacy

摘　　要：目的　探讨黄芪、当归在肾病综合征治疗中的疗效及作用机制。方法　将肾病综合征病人随机分为治疗组、对照组 ,分别采用常规治疗加黄芪、当归煎服和单纯常规治疗。观察两组病人治疗前后尿蛋白、血浆白蛋白和生活质量的变化。结果　治疗 2～ 3个月后 ,治疗组尿蛋白完全缓解、明显缓解、部分缓解、无效者分别为 3 8 1% (8/ 2 1)、3 3 3 % (7/ 2 1)、19 1% (4/ 2 1)、9 5 % (2 / 2 1) ,与对照组相比差异无显著意义 (P >0 0 5 ) ;血浆白蛋白治疗后两组比较差异有显著意义 (P <0 0 1) ;治疗组病人生活质量的改善较对照组明显。结论　黄芪、当归不能直接减少尿蛋白 ,但可以明显提高血浆白蛋白 。Objective To investigate and explore the cure rate of astragalus and angelica on the treatment in patients with nephrotic syndrome(NS) and its mechanism.Methods The routine treatment with astragalus,angelica and simple routine treatment were taken in group A and group B respectively.The level of albuminuria,serum albumin before and after treatment were detected respectively.Results After treatment for 2～3 months,the rate of remission,obvious remission,part remission,inefficacy were 38.1%(8/21),33.3%(7/21),19.1%(4/21),9.5%(2/21) respectively.There was no significant difference in group A than that in group B(P>0.05).For the levels of serum albumin after treatment there was very significant difference between two groups(P<0.01).The change of living standard was better in group A than that in group B.Conclusion Astragalua and angelice increase the level of plasma albumin,and improve the living standard of the patients,and do not decrease the level of albuminuria directly.

关 键 词：黄芪 当归 肾病综合征 疗效 

分 类 号：R277.51[医药卫生—中医学]